Sélectionner la langue

Inscription gratuite

Quote Inquiry/Quick Order

Mon panier

Anti-CD3 Antibody

Demande de produit

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
Plerixafor/Tacrolimus Hydrate	MRG-001(MedRegen); AMD3100+FK506	Phase 2 Clinical	MedRegen LLC	Hepatitis, Alcoholic; Motor Neuron Disease; Cytokine Release Syndrome; Respiratory Tract Diseases; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Abdominal Injuries; Wounds and Injuries; Amyotrophic Lateral Sclerosis; Respiratory Insufficiency	Details
Rimiducid	AP-1903	Phase 2 Clinical	Ariad Pharmaceuticals Inc, Bellicum Pharmaceuticals Inc	Neuroblastoma; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Uveal melanoma; Anemia, Aplastic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Metabolic Diseases; Prostatic Neoplasms; Osteopetrosis; Osteosarcoma; Sarcoma; Blastic Plasmacytoid Dendritic Cell Neoplasm; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Anemia, Sickle Cell; Leukemia, Biphenotypic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Congenital Bone Marrow Failure Syndromes; Melanoma; Thalassemia; Leukemia, Myelogenous, Chronic; Bone Marrow Neoplasms; Leukemia; Hematologic Neoplasms; Lymphoma, B-Cell; Neoplasm, Residual; Solid tumours; Immunoproliferative Disorders; Leukemia, Lymphoid; Lymphatic Diseases; Primary Immunodeficiency Diseases; Anemia, Diamond-Blackfan; Graft vs Host Disease; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Myeloproliferative Disorders; Hemoglobinopathies; Fanconi Anemia; Neoplasms; Immune System Diseases	Details

Informations sur les médicaments commercialisés

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Plus ancien nom de marque	Pays d'approbation le plus ancien	Indication la plus ancienne	Société d'approbation la plus ancienne	Date d'approbation la plus ancienne	Indication	Essai clinique
Tacrolimus Hydrate	LCP-Tacro; FR-900506; L-679934; FK-506MR; FK-506E; FK-506; MR-4; RTU-007	Approved	Astellas Pharma Inc	Protopy, Graceptor (as hydrate), Protopic, Prograf (as hydrate), Hecoria (as hydrate), Hexal, Envarsus XR, Talymus, 普乐可复, Advagraf, Envarsus, Modigraf, Astagraf XL, TacroBell	United States	Rejection in heart transplantation; Rejection of renal transplantation; Rejection of liver transplantation	Astellas Pharma Us Inc	1994-04-08	Keratoconjunctivitis; Dry Eye Syndromes; Conjunctivitis; Psoriasis; Pulmonary Arterial Hypertension; Amputation, Traumatic; Burns; Asthma; Surgical Wound Infection; Colitis, Ulcerative; Rejection in heart transplantation; Infertility, Female; Lupus Nephritis; Hamman-Rich Syndrome; Nephrotic Syndrome; Renal Insufficiency, Chronic; Wounds and Injuries; Vitiligo; Dermatitis, Atopic; Peripheral Nerve Injuries; Ocular inflammation; Edema; Encephalitis; Crohn Disease; Glomerulonephritis, IGA; Rejection of renal transplantation; Reperfusion Injury; Myasthenia Gravis; Medication Adherence; Keratoconjunctivitis Sicca; Genital Diseases, Male; Bone marrow transplant rejection; Liver Failure; Rejection of lung transplantation; Rejection of liver transplantation; Renal Insufficiency; Polymyositis; Primary Graft Dysfunction; Rejection of pancreatic transplantation; Keratoplasty rejection; Dermatomyositis; Kidney Diseases; Lupus Erythematosus, Cutaneous; Graft vs Host Disease; Arthritis, Rheumatoid; Lung Diseases, Intersti	Details

Demande de produit
Informations sur les médicaments commercialisés
Informations sur les médicaments cliniques

Retour sur le site web

Nous contacter

+41 800 040 012

order.fr@acrobiosystems.com
tech.fr@acrobiosystems.com